JJ discontinues dengue drug study after changes in RD portfolio
Oct 04, 2024
Johnson & Johnson said it will discontinue a mid-stage field study evaluating the efficacy of its experimental pill for the prevention of dengue.
https://www.cnbc.com/2024/10/04/jj-discontinues-dengue-drug-study-after-changes-in-rd-portfolio.html
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service